SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4
F Onodi, L Bonnet-Madin, L Meertens, L Karpf… - Journal of Experimental …, 2021 - rupress.org
Several studies have analyzed antiviral immune pathways in late-stage severe COVID-19.
However, the initial steps of SARS-CoV-2 antiviral immunity are poorly understood. Here we …
However, the initial steps of SARS-CoV-2 antiviral immunity are poorly understood. Here we …
[PDF][PDF] SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4
F Onodi, L Bonnet-Madin, L Meertens, L Karpf… - J. Exp …, 2021 - scienceopen.com
Several studies have analyzed antiviral immune pathways in late-stage severe COVID-19.
However, the initial steps of SARS-CoV-2 antiviral immunity are poorly understood. Here we …
However, the initial steps of SARS-CoV-2 antiviral immunity are poorly understood. Here we …
SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4.
F Onodi, L Bonnet-Madin, L Meertens, L Karpf, J Poirot… - 2021 - cabidigitallibrary.org
Several studies have analyzed antiviral immune pathways in late-stage severe COVID-19.
However, the initial steps of SARS-CoV-2 antiviral immunity are poorly understood. Here we …
However, the initial steps of SARS-CoV-2 antiviral immunity are poorly understood. Here we …
SARS-CoV-2 induces human plasmacytoid pre-dendritic cell diversification via UNC93B and IRAK4
F Onodi, L Bonnet-Madin, L Meertens, L Karpf, J Poirot… - bioRxiv, 2020 - biorxiv.org
Several studies have analyzed antiviral immune pathways in late-stage severe COVID-19.
However, the initial steps of SARS-CoV-2 antiviral immunity are poorly understood. Here, we …
However, the initial steps of SARS-CoV-2 antiviral immunity are poorly understood. Here, we …
SARS-CoV-2 induces human plasmacytoid pre-dendritic cell diversification via UNC93B and IRAK4
F Onodi, L Bonnet-Madin, L Meertens… - Journal of …, 2021 - hero.epa.gov
Several studies have analyzed antiviral immune pathways in late-stage severe COVID-19.
However, the initial steps of SARS-CoV-2 antiviral immunity are poorly understood. Here, we …
However, the initial steps of SARS-CoV-2 antiviral immunity are poorly understood. Here, we …
SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4
F Onodi, L Bonnet-Madin, L Meertens, L Karpf… - Journal of Experimental …, 2021 - cir.nii.ac.jp
抄録< jats: p> Several studies have analyzed antiviral immune pathways in late-stage
severe COVID-19. However, the initial steps of SARS-CoV-2 antiviral immunity are poorly …
severe COVID-19. However, the initial steps of SARS-CoV-2 antiviral immunity are poorly …
[HTML][HTML] SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4
F Onodi, L Bonnet-Madin, L Meertens… - The Journal of …, 2021 - ncbi.nlm.nih.gov
Several studies have analyzed antiviral immune pathways in late-stage severe COVID-19.
However, the initial steps of SARS-CoV-2 antiviral immunity are poorly understood. Here we …
However, the initial steps of SARS-CoV-2 antiviral immunity are poorly understood. Here we …
[PDF][PDF] SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4
F Onodi, L Bonnet-Madin, L Meertens, L Karpf… - J. Exp …, 2021 - scholar.archive.org
Several studies have analyzed antiviral immune pathways in late-stage severe COVID-19.
However, the initial steps of SARS-CoV-2 antiviral immunity are poorly understood. Here we …
However, the initial steps of SARS-CoV-2 antiviral immunity are poorly understood. Here we …
SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4
F Onodi, L Bonnet-Madin, L Meertens, L Karpf… - Journal of Experimental …, 2021 - rupress.org
Disclosures: J.-M. Molina reported grants from Gilead and personal fees from Merck, ViiV,
and Janssen outside the submitted work. V. Soumelis reported grants from Sanofi and …
and Janssen outside the submitted work. V. Soumelis reported grants from Sanofi and …
SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4
F Onodi, L Bonnet-Madin… - The Journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Several studies have analyzed antiviral immune pathways in late-stage severe COVID-19.
However, the initial steps of SARS-CoV-2 antiviral immunity are poorly understood. Here we …
However, the initial steps of SARS-CoV-2 antiviral immunity are poorly understood. Here we …